Skip to Main Content
Frequently Asked Questions
Submit an ETD
Global Search Box
Need Help?
Keyword Search
Participating Institutions
Advanced Search
School Logo
Files
File List
case1115318623.pdf (2.62 MB)
ETD Abstract Container
Abstract Header
DISCOVERING THE MOLECULAR AND CELLULAR MECHANISMS UNDERLYING FENFLURAMINE-INDUCED CARDIOPULMONARY SIDE EFFECTS
Author Info
Setola, Vincent
Permalink:
http://rave.ohiolink.edu/etdc/view?acc_num=case1115318623
Abstract Details
Year and Degree
2005, Doctor of Philosophy, Case Western Reserve University, Biochemistry.
Abstract
G protein-coupled receptors (GPCRs) are plasma membrane proteins that act as sensors for extracellular stimuli (e.g., photons, neurohumoral moduluators, odorants and tastants, lipids). The cognate stimulus for a GPCR induces a conformational change that catalyzes, via heterotrimeric G proteins, a series of biochemical reactions inside the cell (i.e., a response); the responses can lead to phenomena such as differentiation, morphological changes, chemotaxis, and mitosis. G protein-coupled receptors are the targets of, in addition to endogenous neurohumoral molecules, more than 30% of currently marketed pharmaceutical drugs. For instance, the effective appetite suppressant fenfluramine reduces appetite via activation of serotonin (5-hydroxytryptamine, 5-HT) 2C (5-HT2C) receptors. Fenfluramine was, despite its efficacy as an anorexigen, withdrawn from market due to its association with life-threatening cardiovascular side effects [i.e., valvular heart disease (VHD) and pulmonary hypertension (PH)]. The work presented in this thesis describes efforts to identify the cellular and molecular mechanisms responsible for fenfluramine-induced VHD. Evidence is presented that both fenfluramine and, to a greater extent, its major in vivo metabolite norfenfluramine, activate mitogenic 5-HT2B receptors, which are expressed in human heart valve interstitial cells (VICs). Both fenfluramine and norfenfluramine induce mitogenic responses from VICs in vitro that are abrogated by a 5-HT2B receptor antagonist. Further, data implicating van der Waals’ (vdW) interactions between the α-methyl group of S-(+)-norfenfluramine and a valine in the second transmembrane helix of the receptor (V2.53) in the compound’s valvulopathic—but not anorexigenic—effects are described. The implication of the findings described herein on preventing drug-associated cardiopulmonary side effects and developing safe, effective anorexigens are also discussed.
Committee
Bryan Roth (Advisor)
Subject Headings
Chemistry, Biochemistry
Keywords
5-HT2B
;
5-HT2B Receptors
;
Receptors
;
SNF
;
V2.53L
;
Fenfluramine
;
5-HT2C
Recommended Citations
Refworks
EndNote
RIS
Mendeley
Citations
Setola, V. (2005).
DISCOVERING THE MOLECULAR AND CELLULAR MECHANISMS UNDERLYING FENFLURAMINE-INDUCED CARDIOPULMONARY SIDE EFFECTS
[Doctoral dissertation, Case Western Reserve University]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=case1115318623
APA Style (7th edition)
Setola, Vincent.
DISCOVERING THE MOLECULAR AND CELLULAR MECHANISMS UNDERLYING FENFLURAMINE-INDUCED CARDIOPULMONARY SIDE EFFECTS.
2005. Case Western Reserve University, Doctoral dissertation.
OhioLINK Electronic Theses and Dissertations Center
, http://rave.ohiolink.edu/etdc/view?acc_num=case1115318623.
MLA Style (8th edition)
Setola, Vincent. "DISCOVERING THE MOLECULAR AND CELLULAR MECHANISMS UNDERLYING FENFLURAMINE-INDUCED CARDIOPULMONARY SIDE EFFECTS." Doctoral dissertation, Case Western Reserve University, 2005. http://rave.ohiolink.edu/etdc/view?acc_num=case1115318623
Chicago Manual of Style (17th edition)
Abstract Footer
Document number:
case1115318623
Download Count:
1,721
Copyright Info
© 2005, all rights reserved.
This open access ETD is published by Case Western Reserve University School of Graduate Studies and OhioLINK.